| |
| |
|
| Insider
Information: |
Milne George M Jr |
| Relationship: |
|
| City: |
Niantic |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
885,931 |
|
|
Indirect Shares
|
1,604,180 |
|
|
| Direct
Value |
$18,867,870 |
|
|
|
Indirect Value
|
$4,173,196 |
|
|
| Total
Shares |
2,490,111 |
|
|
| Total
Value |
$23,041,066 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
2
|
|
Stock
price went up :
|
1
|
2
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
 18.3%
|
75.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mettler Toledo International Inc |
MTD |
Director |
2016-02-22 |
9,548 |
2016-02-22 |
3,180 |
Premium* |
|
|
Charles River Laboratories Inter... |
CRL |
Director |
2021-05-07 |
29,079 |
2021-05-07 |
1,000 |
Premium* |
|
|
Athersys Inc (New) |
ATHX |
Director |
2007-06-08 |
10,000 |
2007-06-08 |
1,600,000 |
Premium* |
|
|
Aurinia Pharmaceuticals Inc |
AUPH |
Director |
2023-05-18 |
78,733 |
2021-03-05 |
0 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-01-25 |
758,571 |
2022-01-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLX |
Amylyx Pharmaceuticals, I... |
|
– • – |
2024-01-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,100 |
758,571 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
|
– • – |
2024-01-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
94,350 |
767,671 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Director |
– • – |
2023-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,733 |
78,733 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Director |
– • – |
2023-03-16 |
4 |
AS |
$31.86 |
$1,116,072 |
D/D |
(35,000) |
862,021 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Director |
– • – |
2023-03-02 |
4 |
B |
$8.91 |
$178,284 |
D/D |
20,000 |
70,000 |
2.39 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Director |
– • – |
2022-03-04 |
4 |
B |
$10.82 |
$54,100 |
D/D |
5,000 |
50,000 |
2.39 |
% |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Director |
– • – |
2022-01-06 |
4 |
B |
$19.00 |
$499,985 |
D/D |
26,315 |
221,396 |
2.39 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
662 |
29,079 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Director |
– • – |
2021-03-05 |
4 |
B |
$13.00 |
$65,000 |
D/D |
5,000 |
45,000 |
2.39 |
% |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2021-03-01 |
4 |
S |
$290.01 |
$1,023,730 |
D/D |
(3,530) |
28,417 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2021-03-01 |
4 |
OE |
$52.29 |
$184,584 |
D/D |
3,530 |
31,947 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,380 |
28,417 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2020-02-18 |
4 |
OE |
$43.39 |
$395,572 |
D/D |
7,170 |
34,207 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2020-02-18 |
4 |
S |
$176.07 |
$1,262,430 |
D/D |
(7,170) |
27,037 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2019-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,694 |
27,037 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2019-02-22 |
4 |
S |
$143.00 |
$649,220 |
D/D |
(4,540) |
24,343 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2019-02-22 |
4 |
OE |
$33.93 |
$154,042 |
D/D |
4,540 |
28,883 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,843 |
29,583 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-03-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,280 |
26,740 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-03-09 |
4 |
AS |
$115.00 |
$890,100 |
D/D |
(7,740) |
29,020 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2018-03-09 |
4 |
OE |
$40.27 |
$311,690 |
D/D |
7,740 |
36,760 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2017-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,470 |
32,000 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2017-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,470 |
32,000 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2017-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,470 |
32,000 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Director |
• • – |
2017-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,470 |
32,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
